These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 19545336

  • 1. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
    Bakowski D, Wozakowska-Kaplon B, Opolski G.
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B, Opolski G.
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [Abstract] [Full Text] [Related]

  • 6. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B, Bartkowiak R, Grabowska U, Janiszewska G.
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
    Sayama H, Nakamura Y, Saitou N, Doi Y, Matsukura S, Sakurai H, Kinoshita M.
    Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B, Opolski G.
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
    Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS, CREED Investigstors. The Cardiovascular Risk Extended Evaluation.
    Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Natriuretic peptides in patients with atrial fibrillation.
    Wozakowska-Kapłon B, Opolski G, Herman Z, Kosior D.
    Cardiol J; 2008 Apr; 15(6):525-9. PubMed ID: 19039756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, Vuolteenaho O, Hartikainen J.
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y.
    Am J Nephrol; 2001 Mar; 21(2):112-9. PubMed ID: 11359018
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.